missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Y-27632 dihydrochloride
Description
Y-27632 dihydrochloride is a Y-27632 synthesized to cGMP guidelines. Suitable for use as an ancillary reagent in the further manufacturing of cell therapies.
For more information about how Y-27632 may be used, please see our protocols: Transdifferentiating Fibroblasts into Neurons, Converting Fibroblasts into Cardiomyocytes (9C Cocktail), Accelerated Induction of Cortical Neurons from hiPSCs, Human iPSC-derived Myoblasts .
Research use only Y-27632 also available.
Spécifications
Spécifications
| Nom ou substance chimique | trans-4-[(1R)-1-Aminoethyl]-N-4-pyridinylcyclohexanecarboxamide dihydrochloride |
| CAS | 129830-38-2 |
| Quantité | 10 mg |
| Gamme de produit | Tocris |
| Cible | Rho-kinase Inhibitors |
| Formule moléculaire | C14H21N3O.2HCl |
| Pureté | 99% |
| Statut réglementaire | GMP |